<!DOCTYPE html><html class="" data-reactroot=""><head><meta charSet="utf-8"/><meta name="save" content="history"/><meta http-equiv="X-UA-Compatible" content="IE=edge"/><meta name="baidu-site-verification" content="VWGb6TyYx8"/><meta content="表皮生长因子受体 - 搜狗科学百科" name="keywords"/><meta content="搜狗科学百科是一部有着平等、协作、分享、自由理念的网络科学全书，为每一个互联网用户创造一个涵盖所有领域知识、服务的中文知识性平台。" name="description"/><meta http-equiv="x-dns-prefetch-control" content="on"/><meta name="server" baike="235" ip="210" env="online"/><link rel="dns-prefetch" href="//cache.soso.com"/><link rel="dns-prefetch" href="//hhy.sogoucdn.com"/><link rel="dns-prefetch" href="//pic.baike.soso.com"/><link rel="dns-prefetch" href="//ugc.qpic.cn"/><link rel="dns-prefetch" href="//xui.ptlogin2.qq.com"/><link rel="dns-prefetch" href="//q1.qlogo.cn"/><link rel="dns-prefetch" href="//q2.qlogo.cn"/><link rel="dns-prefetch" href="//q3.qlogo.cn"/><link rel="dns-prefetch" href="//q4.qlogo.cn"/><link rel="dns-prefetch" href="//q.qlogo.cn"/><link rel="dns-prefetch" href="//img01.sogoucdn.com"/><link rel="dns-prefetch" href="//img02.sogoucdn.com"/><link rel="dns-prefetch" href="//img03.sogoucdn.com"/><link rel="dns-prefetch" href="//img04.sogoucdn.com"/><link rel="Shortcut Icon" href="//www.sogou.com/images/logo/new/favicon.ico?v=4"/><link rel="Bookmark" href="//www.sogou.com/images/logo/new/favicon.ico?v=4"/><link href="//hhy.sogoucdn.com/deploy/ued/new_baike/pc/dist/css/base_b849887.css" rel="stylesheet"/><link href="//hhy.sogoucdn.com/deploy/ued/new_baike/pc/dist/css/detail/detail_378aed5.css" rel="stylesheet"/><link href="//hhy.sogoucdn.com/deploy/ued/new_baike/pc/dist/css/inviteAudit/inviteAudit_7894507.css" rel="stylesheet"/><link rel="stylesheet" href="//hhy.sogoucdn.com/js/lib/highlight/highlight.min.css"/><title>表皮生长因子受体 - 搜狗科学百科</title></head><body><script>window._gtag=window._gtag||{};window._gtag.shouldGrayed = false;if ('360c4a6b95fd4b56a744bdc87e3e4145') window._gtag.traceId = '360c4a6b95fd4b56a744bdc87e3e4145';if ({"illegality":true}) window.userInfo = {"illegality":true};</script><div class="topnavbox"><ul class="topnav"><li><a href="//www.sogou.com/web?query=">网页</a></li><li><a href="//weixin.sogou.com/weixin?p=75351201">微信</a></li><li><a href="//zhihu.sogou.com/zhihu?p=75351218">知乎</a></li><li><a href="//pic.sogou.com/pics?query=">图片</a></li><li><a href="//v.sogou.com/v?query=">视频</a></li><li><a href="//mingyi.sogou.com/">医疗</a></li><li class="cur"><strong>科学</strong></li><li><a href="//hanyu.sogou.com/">汉语</a></li><li><a href="//wenwen.sogou.com/">问问</a></li><li><a href="//www.sogou.com/docs/more.htm">更多<span class="topraquo">»</span></a></li></ul></div><div id="header"><div class="header-wrap"><a class="header-logo" href="/kexue"></a><div class="header-search"><div class="querybox" id="suggBox"></div></div><div class="header-rgt"><span class="btn-header-rgt btn-edit" id="editLemma">创建</span><div class="header-user no-login"></div></div></div></div><div class="fixed-placeholder" style="visibility:none"></div><div id="container" class=""><div class="content lemma-level1"><div class="detail-title" id="abstract-title"><h1>表皮生长因子受体</h1><a href="#!" class="detail-edit">编辑</a></div><div class="section_content" data-id="60049615470263813"><div><p>表皮生长因子受体（Epidermal growth factor receptor, EGFR）是一种负责与表皮生长因子（EGF）结合的跨膜受体蛋白，具有酪氨酸激酶活性，与EGF结合后可通过多条信号通路促进细胞分裂与增殖。表皮生长因子受体是由美国生物化学家斯坦利·科恩（Stanley Cohen）在发现表皮生长因子时一并发现的，科恩也因此荣获1986年诺贝尔生理与医学奖。<sup><a href="#quote_1" class="kx_ref">[1]</a></sup>近年来，表皮生长因子受体被发现与许多癌症的发生和进展有着密切联系，针对表皮生长因子受体的抑制剂也成为了抗癌领域的研究热点。</p></div></div><div id="catalog"></div><div id="paragraphs"></div><div id="references"></div><div class="read-num">阅读 <!-- -->1820</div></div><div class="right-side" id="rightSide"></div></div><div class="footer-box"><div id="footer"><div class="footer-logo-wrap"><div class="footer-logo"></div><div class="footer-logo-text">知识·传播·科普</div></div><div class="footer-info">本网站内容采用<a target="_blank" href="https://creativecommons.org/licenses/by-sa/3.0/deed.zh?tdsourcetag=s_pctim_aiomsg">CC-BY-SA 3.0</a>授权</div><div class="footer-btn-wrap"><a target="_blank" href="https://baike.sogou.com/help/#user_protocol">用户协议</a><a target="_blank" href="http://www.sogou.com/docs/terms.htm?v=1">免责声明</a><a target="_blank" href="http://corp.sogou.com/private.html">隐私政策</a><a target="_blank" href="https://baike.sogou.com/kexue/intro.htm">关于我们</a></div></div></div><script>window.lemmaInfo ={"lemmaId":"15537804402491912","versionId":"60049615436709391","title":"表皮生长因子受体","subtitle":"","abstracts":{"paragraphId":"60049615470263813","title":"摘要","versionId":"60049615436709392","lemmaId":15537804402491912,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1603088359,"comment":null,"dependVersionId":0,"contentType":2,"content":"<p>表皮生长因子受体（Epidermal growth factor receptor, EGFR）是一种负责与表皮生长因子（EGF）结合的跨膜受体蛋白，具有酪氨酸激酶活性，与EGF结合后可通过多条信号通路促进细胞分裂与增殖。表皮生长因子受体是由美国生物化学家斯坦利·科恩（Stanley Cohen）在发现表皮生长因子时一并发现的，科恩也因此荣获1986年诺贝尔生理与医学奖。<sup><a href=\"#quote_1\" class=\"kx_ref\">[1]</a></sup>近年来，表皮生长因子受体被发现与许多癌症的发生和进展有着密切联系，针对表皮生长因子受体的抑制剂也成为了抗癌领域的研究热点。</p>","pics":null,"card":null,"references":[],"versionCount":0},"card":{"paragraphId":"0","title":"","versionId":"0","lemmaId":0,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":0,"comment":null,"dependVersionId":0,"contentType":0,"content":"","pics":null,"card":null,"references":null,"versionCount":0},"categories":[{"id":144,"name":"多肽与蛋白质生物化学","parents":[[{"id":4,"name":"生物学","parents":null},{"id":143,"name":"生物化学","parents":null}]]}],"creator":{"uid":77532282,"name":"胡天楠","pic":"https://cache.soso.com/thirdwx_qlogo/mmopen/vi_32/Q0j4TwGTfTLlveSnKicrOD8ABGuGOT9lFkMd2wGmfl9v8GXuuCVCL5icB4IXMskU1xtQ1YDP2Yv5orkDQCZicYTIA/132","introduction":"","educations":[{"schoolName":"加州大学戴维斯分校","major":"","degree":"博士","universityId":114,"universityLogo":"","majorLevel1":null,"majorLevel2":null,"majorLevel3":null,"majorLevel1Id":0,"majorLevel2Id":0,"majorLevel3Id":0,"state":"毕业","lab":"","researchField":""}],"jobs":[{"company":"加州大学旧金山分校","title":"Assistant Specialist"}],"works":null,"educationBrief":"加州大学戴维斯分校","jobBrief":"Assistant Specialist","role":0,"roleName":null,"title":"加州大学戴维斯分校 · 博士","professionalTitle":"加州大学旧金山分校助理研究员","phoneNo":null,"editable":true,"partnerId":11,"partnerIdCreateTime":1594286496,"partnerIdPoped":true},"createTime":1576557253,"editor":{"uid":77532282,"name":"胡天楠","pic":"https://cache.soso.com/thirdwx_qlogo/mmopen/vi_32/Q0j4TwGTfTLlveSnKicrOD8ABGuGOT9lFkMd2wGmfl9v8GXuuCVCL5icB4IXMskU1xtQ1YDP2Yv5orkDQCZicYTIA/132","introduction":"","educations":[{"schoolName":"加州大学戴维斯分校","major":"","degree":"博士","universityId":114,"universityLogo":"","majorLevel1":null,"majorLevel2":null,"majorLevel3":null,"majorLevel1Id":0,"majorLevel2Id":0,"majorLevel3Id":0,"state":"毕业","lab":"","researchField":""}],"jobs":[{"company":"加州大学旧金山分校","title":"Assistant Specialist"}],"works":null,"educationBrief":"加州大学戴维斯分校","jobBrief":"Assistant Specialist","role":0,"roleName":null,"title":"加州大学戴维斯分校 · 博士","professionalTitle":"加州大学旧金山分校助理研究员","phoneNo":null,"editable":true,"partnerId":11,"partnerIdCreateTime":1594286496,"partnerIdPoped":true},"editTime":1579302348,"state":1,"versionCount":5,"upNum":123,"downNum":0,"pics":[{"originalUrl":"https://img01.sogoucdn.com/app/a/200698/1453_1295_20191230142605-2084829886.jpg?w=1453&h=1295&titlename=EGFR%E6%B4%BB%E5%8C%96%E6%9C%BA%E7%90%86%E7%A4%BA%E6%84%8F%E5%9B%BE","url":"https://img01.sogoucdn.com/app/a/200698/1453_1295_20191230142605-2084829886.jpg","rw":1453,"rh":1295,"title":"EGFR活化机理示意图","alt":null,"width":0,"height":0},{"originalUrl":"https://img04.sogoucdn.com/app/a/200698/672_498_20191230142621-1722338786.png?w=672&h=498&titlename=EGFR%E4%B8%8B%E6%B8%B8%E7%9A%84%E9%83%A8%E5%88%86%E4%BF%A1%E5%8F%B7%E9%80%9A%E8%B7%AF%EF%BC%8C%E5%9B%BE%E4%B8%AD%E4%B8%BB%E8%A6%81%E6%98%BE%E7%A4%BAMAPK%E5%92%8CPI3K-AKT-mTOR%E9%80%9A%E8%B7%AF%E3%80%82","url":"https://img04.sogoucdn.com/app/a/200698/672_498_20191230142621-1722338786.png","rw":672,"rh":498,"title":"EGFR下游的部分信号通路，图中主要显示MAPK和PI3K-AKT-mTOR通路。","alt":null,"width":0,"height":0}],"catalogs":[{"level":1,"title":"结构和机理","paragraphId":"16087438631895308","subCatalogs":null},{"level":1,"title":"生理功能和病理作用","paragraphId":"16087438631895309","subCatalogs":null},{"level":1,"title":"相关药物研究","paragraphId":"16087438631895310","subCatalogs":[{"level":2,"title":"EGFR抑制剂","paragraphId":"16087438631895310","subCatalogs":null},{"level":2,"title":"耐药性问题","paragraphId":"16087438631895310","subCatalogs":null},{"level":2,"title":"医学成像中的应用","paragraphId":"16087438631895310","subCatalogs":null}]},{"level":1,"title":"参考文献","paragraphId":"-1","subCatalogs":null}],"paragraphs":[{"paragraphId":"16087438631895308","title":"结构和机理","versionId":"60049615436709393","lemmaId":15537804402491912,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1603088359,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>作为一种单次跨膜蛋白，表皮生长因子受体的结构可以大致分为三个部分。其胞外部分含623个氨基酸，负责与EGF等配体结合，跨膜部分含23个氨基酸，负责耦联胞外部分和胞内部分，胞内部分含542个氨基酸，活化后具有激酶催化活性并可以与其他胞内蛋白接触，触发下游信号通路。<sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup>由于单次跨膜蛋白的特殊性，EGFR的完整结构目前仍未能被解析。虽然如此，科学家仍通过X射线晶体衍射、NMR等一系列手段分别对其胞外、胞内和跨膜结构域进行了大量的结构分析，并拼凑出一张较为完整的画面。</p><p><img width=\"480\" class=\"ed_imgfloat_embedmiddle\" titlename=\"EGFR活化机理示意图\" bigsrc=\"https://img01.sogoucdn.com/app/a/200698/1453_1295_20191230142605-2084829886.jpg\" data-align=\"embedmiddle\" data-src=\"https://img01.sogoucdn.com/app/a/200698/1453_1295_20191230142605-2084829886.jpg\"></p><p>EGFR在未与配体结合时主要以单体形式存在于细胞表面。当EGFR与EGF结合后，EGFR的胞外部分形成对称的二聚体，并通过跨膜部分诱导EGFR的胞内部分形成非对称的二聚体，其中一个EGFR的胞内部分被活化并产生激酶（可以使氨基酸磷酸化）活性，并导致另一个EGFR的胞内部分磷酸化。被磷酸化的这个EGFR的胞内部分可以接下来被含SH2/PTB结构域的蛋白识别，并激活一系列下游信号通路。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup></p><p>EGFR调控的下游信号通路非常广泛且复杂，其中研究的较多的有RAS-RAF-MEK-ERK通路（又称MAPK通路）、PI3K-AKT-mTOR通路、PLC-γ1-PKC通路等。其中，MAPK通路的调节功能主要是通过活化促分裂基因的转录因子，增加促分裂基因（如CYCLIN-D1）的表达，从而实现促进细胞分裂的作用。而在PI3K-AKT-mTOR通路中，作为细胞能量感受器的mTOR活性增加，导致一系列能量代谢途径的改变（如肿瘤细胞中的Warburg效应），从而满足细胞快速分裂所需的能量供应。<sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup>正因为EGFR可以从许多角度促进细胞分裂和增殖，EGFR的活性变化在许多癌症的发生或进展中起到了关键作用，使得EGFR成为了抗肿瘤药物研发的热门靶点。</p><p><img width=\"480\" class=\"ed_imgfloat_embedmiddle\" titlename=\"EGFR下游的部分信号通路，图中主要显示MAPK和PI3K-AKT-mTOR通路。\" bigsrc=\"https://img04.sogoucdn.com/app/a/200698/672_498_20191230142621-1722338786.png\" data-align=\"embedmiddle\" data-src=\"https://img04.sogoucdn.com/app/a/200698/672_498_20191230142621-1722338786.png\"></p>","pics":[{"originalUrl":"https://img01.sogoucdn.com/app/a/200698/1453_1295_20191230142605-2084829886.jpg?w=1453&h=1295&titlename=EGFR%E6%B4%BB%E5%8C%96%E6%9C%BA%E7%90%86%E7%A4%BA%E6%84%8F%E5%9B%BE","url":"https://img01.sogoucdn.com/app/a/200698/1453_1295_20191230142605-2084829886.jpg","rw":1453,"rh":1295,"title":"EGFR活化机理示意图","alt":null,"width":0,"height":0},{"originalUrl":"https://img04.sogoucdn.com/app/a/200698/672_498_20191230142621-1722338786.png?w=672&h=498&titlename=EGFR%E4%B8%8B%E6%B8%B8%E7%9A%84%E9%83%A8%E5%88%86%E4%BF%A1%E5%8F%B7%E9%80%9A%E8%B7%AF%EF%BC%8C%E5%9B%BE%E4%B8%AD%E4%B8%BB%E8%A6%81%E6%98%BE%E7%A4%BAMAPK%E5%92%8CPI3K-AKT-mTOR%E9%80%9A%E8%B7%AF%E3%80%82","url":"https://img04.sogoucdn.com/app/a/200698/672_498_20191230142621-1722338786.png","rw":672,"rh":498,"title":"EGFR下游的部分信号通路，图中主要显示MAPK和PI3K-AKT-mTOR通路。","alt":null,"width":0,"height":0}],"card":null,"references":[],"versionCount":0},{"paragraphId":"16087438631895309","title":"生理功能和病理作用","versionId":"60049615436709394","lemmaId":15537804402491912,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1603088359,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p>表皮生长因子受体在正常个体的生长和发育中有着广泛的生理功能，例如乳腺发育<sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup>、骨生长<sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup>、皮肤损伤修复<sup><a href=\"#quote_6\" class=\"kx_ref\">[6]</a></sup>、口腔黏膜损伤修复<sup><a href=\"#quote_7\" class=\"kx_ref\">[7]</a></sup>等。因此，接受EGFR抑制剂治疗的患者较容易出现皮肤不良反应，包括皮疹/痤疮样皮疹、皮肤干燥、瘙痒和指甲/甲周组织的炎症等。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup>另外，口腔黏膜炎症也是EGFR抑制剂的常见副作用之一。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup></p><p>在癌症的病理中，表皮生长因子受体扮演了重要的角色。有研究表明，在东亚裔人群中，约35%到50%的肺癌患者携带EGFR突变。EGFR突变在非小细胞肺癌，尤其是肺腺癌中最为多见。另外，EGFR突变也更常见于非吸烟者肺癌和年轻肺癌患者中。<sup><a href=\"#quote_9\" class=\"kx_ref\">[9]</a></sup>在结直肠癌中，有报道称60%到80%存在EGFR上调。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup>在胶质母细胞瘤（一种高度恶性的脑癌）中，约50%存在EGFR过表达，另外许多胶质母细胞瘤中还存在一种特殊的EGFR突变（EGFRvIII），该突变导致EGFR无需配体活化便可自发维持活性。<sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup>在头颈部鳞癌中，约80%到90%存在EGFR过表达。<sup><a href=\"#quote_12\" class=\"kx_ref\">[12]</a></sup>总的来说，约30%的上皮系统肿瘤都与EGFR的突变、过表达或失调密切相关。<sup><a href=\"#quote_13\" class=\"kx_ref\">[13]</a></sup></p>","pics":null,"card":null,"references":[],"versionCount":0},{"paragraphId":"16087438631895310","title":"相关药物研究","versionId":"60049615436709395","lemmaId":15537804402491912,"createType":0,"creator":{"uid":0,"name":null,"pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"createTime":0,"versionEditor":{"uid":78021691,"name":"没时间到白头","pic":null,"introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":null,"jobBrief":null,"role":0,"roleName":null,"title":null,"professionalTitle":null,"phoneNo":null,"editable":false,"partnerId":0,"partnerIdCreateTime":0,"partnerIdPoped":false},"editTime":1603088359,"comment":null,"dependVersionId":0,"contentType":1,"content":"<p><h3>EGFR抑制剂</h3></p><p>由于表皮生长因子受体在癌症中扮演的重要作用，近些年来，有很多针对EGFR的抑制剂进入临床应用。根据作用机理的不同，这些抑制剂大体可以分为两类。第一类抑制剂主要包括针对EGFR胞外结构域的人源化单克隆抗体，它们的作用是阻止配体（如EGF）同EGFR接触，从而减少EGFR被激活的程度。<sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup>目前美国药监局（FDA）批准的这类抑制剂有西妥昔单抗（Cetuximab）、帕尼单抗（Panitumumab）、耐昔妥珠单抗（Necitumumab）等。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup>另一类EGFR抑制剂是针对EGFR胞内结构域的酪氨酸激酶抑制剂（TKI），它们通常与EGFR的ATP结合位点结合，从而竞争性阻止ATP在该位点结合，导致EGFR无法催化氨基酸磷酸化（即阻止了激酶活性），从而阻止了下游信号传导。<sup><a href=\"#quote_2\" class=\"kx_ref\">[2]</a></sup>这一类抑制剂大部分是小分子，目前FDA批准的有厄洛替尼（Erotinib）、拉帕替尼（Lapatinib）、吉非替尼（Gefitinib）、奈拉提尼（Neratinib）等。<sup><a href=\"#quote_3\" class=\"kx_ref\">[3]</a></sup></p><p><h3>耐药性问题</h3></p><p>虽然各种EGFR抑制剂的出现一定程度上改善了很多晚期肿瘤患者的预后，但几乎所有的EGFR抑制剂都会在使用一段时间后出现明显的耐药性，从而导致EGFR抑制剂对晚期肿瘤患者的5年生存率改善并不明显。<sup><a href=\"#quote_4\" class=\"kx_ref\">[4]</a></sup>癌细胞对EGFR抑制剂产生耐药性的途径有很多，主要包括以下几种机制<sup><a href=\"#quote_5\" class=\"kx_ref\">[5]</a></sup>：</p><p>\n <ol>\n  <li><p>EGFR的过度表达或配体过度表达。耐药肿瘤细胞可以在细胞表面产生更多的EGFR，或者激活EGFR的配体（如肿瘤生长因子TGF-α）过度表达，使得需要更大剂量的抗体才能阻止EGFR被活化。</p></li>\n  <li><p>EGFR的变体EGFRvIII。该变体为一截短的EGFR，使得其无需配体活化便可自带激酶活性。有研究表明该变体的出现与耐药性有关。</p></li>\n  <li><p>EGFR下游或旁路的信号通路上调。EGFR的下游通路或其他旁路，如RAS、PTEN等蛋白质发生活性增加的突变，抵消了EGFR被抑制的效果。</p></li>\n  <li><p>EGFR的ATP结合位点发生突变，导致原来的小分子抑制剂无法有效阻止其激酶活性。这是导致酪氨酸激酶抑制剂耐药的主要原因。例如，在TKI治疗中，EGFR的T790M突变占病人获得性耐药的50%以上。<sup><a href=\"#quote_6\" class=\"kx_ref\">[6]</a></sup></p></li>\n  <li><p>EGFR抑制剂导致mTOR活性改变，促进自噬，提高肿瘤细胞适应性。mTOR作为EGFR下游的重要一员，其本身在维持细胞能量代谢中具有重要作用。mTOR活性变化可促使细胞通过增强自噬等途径逃过被“饿死”的命运。</p></li>\n </ol></p><p>针对不同的耐药机理，研究人员采用了一系列不同的策略来降低EGFR的耐药性问题。对于EGFR的ATP结合位点突变导致的耐药，通过对这一位点的结构解析，借助计算机模拟等药物设计工具，研究人员可以不断地设计出可以结合EGFR突变体的新型酪氨酸激酶抑制剂，如奥希替尼（Osimertinib）。<sup><a href=\"#quote_7\" class=\"kx_ref\">[7]</a></sup>对于EGFR下游通路或旁路上调导致的耐药，可以通过联合其他靶向药的方式，同时抑制多个通路，以起到最大化杀死癌细胞的效果。<sup><a href=\"#quote_8\" class=\"kx_ref\">[8]</a></sup>另外，利用药物载体同时递送EGFR抑制剂和其他小分子化疗药物可更精确地实现对癌细胞的定向打击，同时减少副作用。<sup><a href=\"#quote_9\" class=\"kx_ref\">[9]</a></sup></p><p><h3>医学成像中的应用</h3></p><p>作为一种在许多肿瘤细胞表面大量表达的分子，EGFR也可以被用于识别肿瘤的标记物，从而应用在肿瘤的医学成像中。将造影剂连接在EGFR抑制剂（小分子或抗体）上，当该分子与EGFR结合后，即可以实现对肿瘤的特异性识别和成像。根据成像原理的不同，研究人员开发了许多不同的EGFR选择性造影剂。例如，将厄洛替尼和纳米氧化铁颗粒共价结合，可以制成对肿瘤选择性成像的核磁共振造影剂。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup>而碳-11标记过的厄洛替尼可以用于正电子发射断层扫描，有助于筛选适用于EGFR抑制剂治疗的癌症患者，从而实现肿瘤的个体化治疗。<sup><a href=\"#quote_11\" class=\"kx_ref\">[11]</a></sup>西妥昔单抗则通常用Zr-89标记后，用于正电子发射断层扫描成像，该造影剂已进入临床试验阶段。<sup><a href=\"#quote_12\" class=\"kx_ref\">[12]</a></sup>另外，通过将化疗药物、造影剂和抗EFGR抗体连接在一起，可以同时实现肿瘤的诊断和靶向治疗的一体化。<sup><a href=\"#quote_10\" class=\"kx_ref\">[10]</a></sup></p>","pics":null,"card":null,"references":[],"versionCount":0}],"references":[{"id":1,"type":"web","title":"Physiology or Medicine Nobel Prize 1986.","site":"Nobel prize","url":"http://www.nobelprize.org/prizes/medicine/1986/press-release/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":2,"type":"web","title":"Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways.","site":"NCBI","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5447962/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":3,"type":"web","title":"Structure-Based View of Epidermal Growth Factor Receptor Regulation.","site":"Annual Review of Biophysics","url":"https://www.annualreviews.org/doi/full/10.1146/annurev.biophys.37.032807.125829?casa_token=DUaAe8R0Y1oAAAAA:nQMLd-VrX_5B4BA5oULqgl04zqRAMADeOGtx6GmWZJCliYHn-9JZXMd2DFfN6GfUEcHA3p8dRmv7j2Q","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":4,"type":"web","title":"Mammary Gland Growth Factors: Roles in Normal Development and in Cancer.","site":"NCBI","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2908768/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":5,"type":"web","title":"The EGFR network in bone biology and pathology.","site":"Cell Press","url":"https://www.cell.com/trends/endocrinology-metabolism/comments/S1043-2760(09)00139-8","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":6,"type":"web","title":"EGFR enhances early healing after cutaneous incisional wounding.","site":"NCBI","url":"https://www.ncbi.nlm.nih.gov/pubmed/15482488","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":7,"type":"web","title":"Unraveling the role of epidermal growth factor receptor in oral lesions: Key to non surgical treatment modes.","site":"World Journal of Stomatology","url":"https://www.wjgnet.com/2218-6263/full/v4/i1/22.htm","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":8,"type":"web","title":"EGFR-TKI不良反应管理专家共识。","site":"NCBI","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6397940/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":9,"type":"web","title":"Epidermal Growth Factor Receptor in Lung Cancer.","site":"EGFResisters","url":"https://egfrcancer.org/about-egfr/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":10,"type":"web","title":"Colon cancer and the epidermal growth factor receptor.","site":"NCBI","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600187/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":11,"type":"web","title":"Epidermal growth factor receptor (EGFR) and EGFRvIII in glioblastoma (GBM).","site":"NCBI","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860944/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":12,"type":"web","title":"Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated with Inactivation of SH3GL2 and CDC25A Genes.","site":"PLoS One","url":"https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063440","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false},{"id":13,"type":"web","title":"Activation of Epidermal Growth Factor Receptor Is Required for NTHi-Induced NF-κB-Dependent Inflammation.","site":"NCBI","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223233/","journalName":null,"author":"","press":"","publishYear":"","publishTime":null,"publishPlace":"","page":"","volume":"","quoteTime":null,"quoted":false}],"recommendReferences":null,"auditState":2,"lemmaLevel":1,"origin":0,"originEnTitle":null,"originZhTitle":null,"pv":1820,"auditType":0,"synonyms":null,"showEditTime":"2020.01.18 07:05","auditors":[{"uid":75234227,"name":"7","pic":"https://cache.soso.com/qlogo/g?b=oidb&k=plvPjjqaNicMYKMwhI6yKUA&s=100&t=1555919297","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":177,"partnerIdCreateTime":1595844898,"partnerIdPoped":true}],"hasZhishiNav":false,"auditInfos":{"0":[{"versionId":"0","auditTime":1579396916,"auditorId":75234227,"auditUser":{"uid":75234227,"name":"7","pic":"https://cache.soso.com/qlogo/g?b=oidb&k=plvPjjqaNicMYKMwhI6yKUA&s=100&t=1555919297","introduction":null,"educations":null,"jobs":null,"works":null,"educationBrief":"","jobBrief":"","role":0,"roleName":null,"title":"","professionalTitle":null,"phoneNo":null,"editable":true,"partnerId":177,"partnerIdCreateTime":1595844898,"partnerIdPoped":true},"auditReason":"通过作者修改","auditSuggest":null,"auditResult":2,"auditAnnotations":null}]},"isHistory":false};</script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/aegis-sdk/latest/aegis.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/common/polyfill/main_2020092401.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/react/17.0.2/react.production.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/react/17.0.2/react-dom.production.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/jquery/jquery-1.11.1.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/common/hhy/main_2022062701.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/deploy/new_baike/pc/general/main_66bbe21.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/react/17.0.2/react.production.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/lib/react/17.0.2/react-dom.production.min.js"></script><script crossorigin="anonymous" src="//hhy.sogoucdn.com/js/deploy/new_baike/pc/detail/main_edf0f08.js"></script><div id="popControl"></div></body></html>